Fabrice Lalloué Selected Research

Fabrice Lalloué Research Topics

Disease

11	Neoplasms (Cancer) 03/2021 - 01/2014
10	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2007
3	Lung Neoplasms (Lung Cancer) 10/2017 - 09/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 09/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2014
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Cognitive Dysfunction 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Glioma (Gliomas) 04/2019
1	Kidney Neoplasms (Kidney Cancer) 06/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015
1	Carcinogenesis 01/2015
1	Neuroblastoma 01/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013
1	B-Cell Leukemia (Leukemia, B Cell) 12/2012
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 10/2011
1	Pulmonary Hypertension 11/2010
1	Systemic Scleroderma (Systemic Sclerosis) 11/2010
1	Pulmonary Arterial Hypertension 11/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2010
1	Vascular Skin Diseases 06/2010
1	Dementia (Dementias) 01/2006

Drug/Important Bio-Agent (IBA)

7	sortilinIBA 01/2021 - 01/2014
5	Nerve Growth Factors (Neurotrophins)IBA 06/2016 - 11/2010
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 08/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 11/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2016 - 01/2014
2	NeurotensinIBA 12/2020 - 12/2012
2	Biological ProductsIBA 12/2020 - 08/2016
2	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2020 - 01/2014
2	SCO-spondinIBA 10/2017 - 01/2014
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 06/2016 - 02/2011
1	Tumor Biomarkers (Tumor Markers)IBA 03/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	TropomyosinIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	src-Family KinasesIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	Bovine Serum AlbuminIBA 01/2019
1	OligopeptidesIBA 10/2017
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 08/2016
1	brain-derived neurotrophic factor precursorIBA 06/2016
1	TESIBA 01/2016
1	interleukin-22 receptor (IL-22R)IBA 01/2015
1	Interleukin-22 (IL-22)IBA 01/2015
1	CollagenIBA 01/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	Amyloid beta-PeptidesIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2012
1	Rheumatoid FactorIBA 10/2011
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2011
1	anti-scl-70 autoantibodiesIBA 11/2010
1	AntibodiesIBA 06/2010
1	Biological FactorsIBA 06/2010
1	Etoposide (VP 16)FDA LinkGeneric 01/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007
1	Fas Ligand Protein (Fas Ligand)IBA 01/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2006
1	Lab-On-A-Chip Devices 10/2021
1	Drug Therapy (Chemotherapy) 03/2021
1	Precision Medicine 12/2020